MoneyWorks4Me

USFDA completes audit at Dr. Reddy’s Laboratories’ Hyderabad plant

12 Jul 2019 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Manufacturing Plant 2 at Bollaram, Hyderabad. The audit was completed on July 12, 2019. The company has been issued a Form 483 with 5 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..